Free Trial
NASDAQ:NIVF

NewGenIvf Group Q2 2026 Earnings Results & Report

NewGenIvf Group logo
$0.93 -0.05 (-5.57%)
Closing price 04:00 PM Eastern
Extended Trading
$0.93 +0.00 (+0.52%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NewGenIvf Group missed analyst expectations on both earnings and revenue in its Q2 2026 results, released October 7, 2026. The company reported EPS of -$111.54 versus the $581.76 consensus estimate, while revenue of $962.44 thousand fell short of the $20.10 million estimate by $19.14 million.

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
After Market Closes

NewGenIvf Group EPS Results

Actual EPS
-$111.54
Consensus EPS
$581.76
Beat/Miss
Missed by -$693.30
One Year Ago EPS
N/A

NewGenIvf Group Revenue Results

Actual Revenue
$962.44 thousand
Expected Revenue
$20.10 million
Beat/Miss
Missed by -$19.14 million
YoY Revenue Growth
N/A

Conference Call Resources

NewGenIvf Group Q2 2026 Earnings FAQ

NewGenIvf Group (NASDAQ:NIVF) reported earnings of -$111.54 per share for Q2 2026, missing the consensus estimate of $581.76. The report was announced on Wednesday, October 7, 2026.

NewGenIvf Group reported revenue of $962.44 thousand for Q2 2026, against a consensus estimate of $20.10 million.

NewGenIvf Group Earnings Headlines

NEVER thought this would happen again
Twenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a household name. Now he says a similar shift is unfolding in AI infrastructure. Hundreds of billions are pouring into AI data centers, but he warns the builders could get crushed by their own costs while one overlooked sector absorbs the spending.tc pixel
NewGenIvf Group Limited Closes $1.25 Million Public Offering
NewGen Announces Closing of $1.25 Million Public Offering
See More NewGenIvf Group Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NewGenIvf Group? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NewGenIvf Group and other key companies, straight to your email.

About NewGenIvf Group

NewGenIvf Group (NASDAQ:NIVF) (NASDAQ:NIVF) is a fertility-services company focused on assisted reproductive technology and related medical care. Through its NewGen IVF operations, the company provides services intended to help individuals and couples pursue pregnancy, including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), fertility assessments and fertility-preservation procedures.

Its service offering also includes egg and sperm freezing, embryo-related services, genetic testing and donor-program support, subject to applicable medical and regulatory requirements. The company serves patients seeking fertility treatment in Southeast Asia, with operations associated with Thailand and an international patient base.

NewGenIvf Group Limited is organized as a holding company, while its fertility clinics and operating subsidiaries deliver medical services. Publicly available information about the company’s historical development and current leadership is limited; accordingly, this description does not identify individual executives or provide additional details that cannot be reliably verified.

View NewGenIvf Group Profile